Conmed Corp.
CNMD
Market Cap$2.19B
Close$
$17.31
75.7% downside
Current Fair Value
75.7% downsideOvervalued by 75.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.19 Billion |
|---|---|
| Enterprise Value | $3.14 Billion |
| Dividend Yield | $0.7975 (1.12%) |
| Earnings per Share | $2.04 |
| Beta | 1.02 |
| Outstanding Shares | 30,791,166 |
| Avg 30 Day Volume | 463,241 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 33.95 |
|---|---|
| PEG | 139.14 |
| Price to Sales | 1.78 |
| Price to Book Ratio | 2.64 |
| Enterprise Value to Revenue | 2.52 |
| Enterprise Value to EBIT | 26.02 |
| Enterprise Value to Net Income | 48 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 1.17 |
Revenue Sources
No data
ESG Score
No data
About Conmed Corp.
CEO: Curt Hartman